Engineered antibodies or possibly mRNA vaccine, maybe. Monoclonal antibodies would likely be too expensive for use as a purely ameliorative measure. But if we f

Engineered antibodies or possibly mRNA vaccine, maybe. Monoclonal antibodies would likely be too expensive for use as a purely ameliorative measure. But if we figure out how to fold proteins on demand, then we can express a sequence and make it like other biologics. That's still a very expensive proposition, but at least it would have economies of scale. Avoidance is the best medicine for sure.